Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine Efficacy and Safety in Major Depressive Disorder
NCT03121573Completed
- Sponsor
- Taichung Veterans General Hospital
- Start
- Dec 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of duloxetine in major depressive disorder (MDD), sponsored by Taichung Veterans General Hospital. Primary endpoint: Change in Depression severity at 12 weeks. Started Dec 2014; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03121573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121573.